ENTITY

Neurocrine Biosciences (NBIX US)

36
Analysis
Health CareUnited States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
Refresh
Company Presentation01 May 2024 20:00
Company Presentation07 Feb 2024 21:00
Company Presentation06 Nov 2018 05:30
Company Presentation06 Feb 2019 05:30
Company Presentation30 Apr 2019 04:30
x